Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 291,238 | 280,140 | 278,686 | 284,723 | 285,981 |
| Cost of Goods | 187,027 | 189,115 | 185,427 | 181,138 | 181,769 |
| Gross Profit | 104,211 | 91,025 | 93,259 | 103,585 | 104,212 |
| Operating Expenses | 61,475 | 56,071 | 56,004 | 54,449 | 61,241 |
| Operating Income | 42,763 | 35,069 | 37,682 | 49,274 | 43,740 |
| Interest Expense | 8,280 | 8,309 | 8,519 | 8,079 | 8,435 |
| Other Income | 1,165 | -555 | -768 | -1,195 | -159 |
| Pre-tax Income | 35,648 | 26,205 | 28,395 | 40,000 | 35,146 |
| Income Tax | 9,722 | 3,488 | 6,011 | 9,453 | 8,676 |
| Net Income Continuous | 25,926 | 22,717 | 22,384 | 30,547 | 26,470 |
| Net Income Discontinuous | -155 | -4,189 | -182 | 42 | 77 |
| Minority Interests | 193 | 112 | 230 | 121 | 108 |
| Net Income | $25,578 | $18,416 | $21,972 | $30,468 | $26,439 |
| EPS Basic Total Ops | 0.54 | 0.39 | 0.46 | 0.63 | 0.55 |
| EPS Basic Continuous Ops | 0.54 | 0.47 | 0.47 | 0.63 | 0.55 |
| EPS Basic Discontinuous Ops | 0.00 | -0.08 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.53 | 0.38 | 0.46 | 0.63 | 0.54 |
| EPS Diluted Continuous Ops | 0.53 | 0.47 | 0.46 | 0.63 | 0.54 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.09 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $67,330 | $60,213 | $62,706 | $73,656 | $68,087 |